![Continuous glucose monitors to be more widely available for type 1 diabetes patients - The Pharmacist Continuous glucose monitors to be more widely available for type 1 diabetes patients - The Pharmacist](https://s3-eu-west-2.amazonaws.com/images.thepharmacist.co.uk/wp-media-folder-the-pharmacist/wp-content/uploads/2022/08/Wider-availability-continuous-glucose-monitors-diabetes.jpg)
Continuous glucose monitors to be more widely available for type 1 diabetes patients - The Pharmacist
![Continuous Glucose Monitoring vs Blood Glucose Meter Monitoring in Type 2 Diabetes - Endocrinology Advisor Continuous Glucose Monitoring vs Blood Glucose Meter Monitoring in Type 2 Diabetes - Endocrinology Advisor](https://www.endocrinologyadvisor.com/wp-content/uploads/sites/9/2021/06/CGM_G_1282091595.jpg)
Continuous Glucose Monitoring vs Blood Glucose Meter Monitoring in Type 2 Diabetes - Endocrinology Advisor
![Electronics | Free Full-Text | Applications of the Internet of Medical Things to Type 1 Diabetes Mellitus Electronics | Free Full-Text | Applications of the Internet of Medical Things to Type 1 Diabetes Mellitus](https://pub.mdpi-res.com/electronics/electronics-12-00756/article_deploy/html/images/electronics-12-00756-g001.png?1675340176)
Electronics | Free Full-Text | Applications of the Internet of Medical Things to Type 1 Diabetes Mellitus
![People with type 1 diabetes in England to be given skin sensor to monitor blood sugar | Diabetes | The Guardian People with type 1 diabetes in England to be given skin sensor to monitor blood sugar | Diabetes | The Guardian](https://i.guim.co.uk/img/media/134915b8b84776142310b66a71e47e247539cd34/0_333_5000_3000/master/5000.jpg?width=1200&height=900&quality=85&auto=format&fit=crop&s=db6222fa7063131512e87988fcbda202)
People with type 1 diabetes in England to be given skin sensor to monitor blood sugar | Diabetes | The Guardian
![Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial - The Lancet Diabetes & Endocrinology Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/20bc29d6-d159-48fd-b1ce-d295bb609cbb/gr1_lrg.jpg)